• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TLX

TELIX PHARMACEUTICALS LIMITED - Corporate Spotlight

3.74% ! $16.98
Market Cap $5.730B  !
Healthcare Biotechnology
Add to My Watchlist

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$16.98 		Change
-0.660(3.74%) 		Mkt cap ! $5.730B
Open High Low Value Volume
$17.42 $17.50 $16.92 $32.98M 1.918M

Buyers (Bids)

No. Vol. Price($)
11 1304 $16.97
 

Sellers (Offers)

Price($) Vol. No.
$16.99 4749 17
View Market Depth
Last trade - 14.30pm 11/08/2025 (20 minute delay) ?
Last
$16.98 		  Change
-0.660 ( 3.55 %)
Open High Low Volume
$17.35 $17.50 $16.93 282138
Last updated 14.48pm 11/08/2025 ?
TLX (ASX) Chart

Top Stories

DroneShield's civilian counter-drone tech lands with a buzz

A silent guardian, standing tall and watching the skies. No, it’s not a superhero, but DroneShield’s (ASX:DRO) newest brainchild, SentryCiv: A new subscription-based counter-drone system for the civilian market.Listen to the HotCopper podcast for in-depth discussio...
Monday's HotCopper trends: DRO civ counterdrone, Dateline drill hits | Aug 11 DroneShield (ASX:DRO) has captured the most attention across the HotCopper forums through Week 33’s first trade day, sparking excitement with its new @SentryCiv,” a subscription-based AI counterdrone solution.Listen to the HotCopper podcast for in-depth discu...
Trump's not talking about Greenland – so why is ETM up +130%? Sixty Minutes is, in many ways, peak boomer. The not-so-shiny-anymore crown jewel of a media brand now more invested in property...
The cash flow on demand strategy that works This week on Money and Investing, Mitch Olarenshaw and I break down the strategy behind Cash Flow on Demand @ a proven system for generating consistent income from the sharemarket with lower risk.1. The cash flow on demand strategyThis income strategy has been our flagship approach at Australian ...
Can the market squeeze IDP Education's shorters? As of Week 33, it looks possible IDP Education (ASX:IEL), a company that ultimately trains up foreign students moving to Australia, has long been one of the most...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.